Australia postpones legislation debate
This article was originally published in Clinica
Australia's Therapeutic Goods Amendment (Medical Devices) Bill 2001 will no longer be debated in parliament during the Winter 2001 sitting as originally planned. This is now scheduled to take place during the Spring 2002 sitting, the Therapeutic Goods Administration (TGA) has announced. The bill, which if enacted will replace the Therapeutic Goods Act 1989, was introduced on 29 March 2001. The new regulatory system was due to be implemented in late 2001.
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”